Press Trust of India | Saturday July 11, 2020, New Delhi
India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat COVID-19 patients with moderate to severe acute respiratory distress, officials told PTI on Friday.
from India News, Latest & Breaking India News, Live India News - NDTV.com https://ift.tt/3iU2Gg6
No comments:
Post a Comment